A
AMSilk
The world’s first industrial supplier of vegan silk biopolymers and has its headquarters in Planegg near Munich, Germany
About AMSilk
AMSilk is a biotechnology company that specializes in the production of bioengineered silk proteins. These innovative materials are designed to be sustainable, high-performing, and capable of addressing global challenges. The company operates in the burgeoning biotech materials market, serving a diverse range of clients across various industries.
Read full description
AMSilk's business model revolves around the production and distribution of these silk proteins, which are renewable, biodegradable, fully recyclable, and have a lower carbon footprint compared to traditional materials. The company's products offer superior performance to petroleum-based, animal-based, or other natural alternatives, making them an attractive choice for businesses looking to reduce their environmental impact.
The company generates revenue through the sale of these materials, either as non-customized products or as part of joint research and development projects. AMSilk also offers a strategic partnership model, where industry leaders can collaborate with the company to develop tailor-made products based on their specific needs.
AMSilk's innovative approach to protein production has resulted in a new strain that delivers unprecedented yield with greater efficiency and lower costs. This has positioned the company as a world-leading provider of structural proteins, and it continues to scale up its operations to meet growing demand.
In summary, AMSilk is a forward-thinking biotech company that is leveraging the power of silk proteins to create sustainable and high-performing materials. Its collaborative approach to business and commitment to sustainability make it a major player in the biotech materials market.
At a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- Planegg, Germany
- Employees
- 81
- Open positions
- 2
- Dealroom signal
- 75.5/100
- Industry
- Health, Fashion
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Publishing, Biotechnology, Synthetic Biology, Spinout, Sustainable Development Goals, Industrial Technology, Tech for Hospitals and Clinics
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Sep 2025 | $57M | $229M | Novo Holdings · MIG Capital · Athos | ↗ |
| SERIES COther financing | Apr 2023 | $28M | $160M | Cargill Ventures | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for AMSilk is 1.4K monthly website visits, down 70.2% over the last three months. AMSilk's team grew 1.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
MIG Capital
Series B and later3 investors entered at this stage
Cargill Ventures
Athos
Novo Holdings
Other known investors1 additional known investor
Technical University Munich
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about AMSilk on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AMSilk’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.